Want better cancer treatments? Make biopharma more like Silicon Valley

Less than a month into her role as CEO of the nonprofit Cancer Research Institute, Alicia Zhou has some big ideas for the future of the organization.

The CRI has funded cutting-edge oncology research, primarily in the field of immunotherapy, since 1953, when the approach was considered experimental and unorthodox. Cut to present day and immuno-oncology has become a major pillar in cancer treatment and research, resulting in some of the world’s best-selling medicines.